Arkolith/Insider Trading/FHTX/Form 4

Costa Carlos

Chief People OfficerFoghorn Therapeutics Inc. (FHTX) · full profile →Form 4 · filed Sep 20, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$116K
Net Open-Market Flow
-$116K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 18, 2024Option exercise(M)12K$3.72$43K12K
Sep 18, 2024Sell(S)12K$10.05$116K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 18, 2024Option exercise(M)12K—$076K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001562180-24-006885) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML